COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE
Trial ID
U31402-A-U201
Sponsor ID
HERTHENA-Lung01
A Phase 2 Randomized Open-Label Study of Patritumab Deruxtecan (U3-1402) in Subjects With Previously Treated Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
Principal Investigator
Alexander I Spira, MD, PhD, FACP
1 Location
Locations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
APG1252SU101
Sponsor ID
A Multi-Center, Phase I/II Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Principal Investigator
Alexander I Spira, MD, PhD, FACP
1 Location
Trial ID
DS1062-A-U301
Sponsor ID
TROPION-Lung01
Phase 3 Randomized Study of DS-1062A Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
Principal Investigator
Alexander I Spira, MD, PhD, FACP
1 Location